 Compound CID,Name,Synonyms,Molecular Weight,Molecular Formula,Polar Area,Complexity,XLogP,Heavy Atom Count,H-Bond Donor Count,H-Bond Acceptor Count,Rotatable Bond Count,InChI,SMILES,InChIKey,IUPAC Name,Exact Mass,Monoisotopic Mass,Charge,Covalent Unit Count,Isotopic Atom Count,Total Atom Stereo Count,Defined Atom Stereo Count,Undefined Atom Stereo Count,Total Bond Stereo Count,Defined Bond Stereo Count,Undefined Bond Stereo Count,Linked PubChem Literature Count,Linked PubChem Patent Count,Linked PubChem Patent Family Count,MeSH Headings,Annotation Content,Annotation Type Count,Linked BioAssays,Create Date,Data Source,Data Source Category,Tagged by PubChem
118238370,Batoprotafib,"TNO155|1801765-04-7|batoprotafib|TNO-155|FPJWORQEGI|SHP2 inhibitor TNO155|PTPN11 inhibitor TNO155|(3S,4S)-8-[6-amino-5-(2-amino-3-chloropyridin-4-yl)sulfanylpyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine|(3S,4S)-8-[6-Amino-5-[(2-amino-3-chloro-4-pyridinyl)thio]-2-pyrazinyl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine|Tno 155|(3S,4S)-8-(6-Amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine|(3S,4S)-8-{6-amino-5-[(2-amino-3-chloropyridin-4-yl)sulfanyl]pyrazin-2-yl}-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine|compound 1 [PMID: 32910655]|(3S,4S)-8-(6-Amino-5-((2-amino-3-chloropyridin-4-yl)sulfanyl)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro(4.5)decan-4-amine|compound 1 (PMID: 32910655)|(3S,4S)-8-(6-amino-5-(2-amino-3-chloropyridin-4-yl)sulfanylpyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro(4.5)decan-4-amine|BCP33299|Batoprotafib [INN]|MFCD32693919|UNII-FPJWORQEGI|CHEMBL4650521|SCHEMBL16914359|TNO 155 [WHO-DD]|GTPL12068|TNO155?|EX-A3645|TNO-155; TNO 155|BDBM50553783|NSC825523|AKOS040740434|NSC-825523|AC-36494|MS-27407|DB-130941|HY-136173|CS-0120271|D81634|(3S,4S)-8-(6-Amino-5-(2-amino-3-chloropyridin-4-ylthio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine|(3S,4S)-8-{6-amino-5-[(2-amino-3-chloropyridin-4- yl)sulfanyl]pyrazin-2-yl}-3-methyl-2-oxa-8- azaspiro[4.5]decan-4-amine|2-Oxa-8-azaspiro[4.5]decan-4-amine, 8-[6-amino-5-[(2-amino-3-chloro-4-pyridinyl)thio]-2-pyrazinyl]-3-methyl-, (3S,4S)-|VKS",421.900,C18H24ClN7OS,155.000,538.000,1.300,28,3,9,3,"InChI=1S/C18H24ClN7OS/c1-10-14(20)18(9-27-10)3-6-26(7-4-18)12-8-24-17(16(22)25-12)28-11-2-5-23-15(21)13(11)19/h2,5,8,10,14H,3-4,6-7,9,20H2,1H3,(H2,21,23)(H2,22,25)/t10-,14+/m0/s1",C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C(C(=N3)N)SC4=C(C(=NC=C4)N)Cl)CO1)N,UCJZOKGUEJUNIO-IINYFYTJSA-N,"(3S,4S)-8-[6-amino-5-(2-amino-3-chloropyridin-4-yl)sulfanylpyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine",421.145,421.145,0,1,0,2,2,0,0,0,0,7,534,172,"",Biological Test Results|Interactions and Pathways|Classification|Drug and Medication Information|Literature|Patents|Associated Disorders and Diseases|Biological Test Results: Active|Biological Test Results: Micromolar,9,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1670043|1694842|1694843|1694844|1697066|1697067|1697069|1697070|1697071|1697077|1697078|1697079|1697080|1697082|1697083|1697084|1697085|1697086|1697087|1697088|1697089|1697090|1697091|1697092|1697093|1697094|1697095|1697096|1697097|1697098|1697099|1697100|1697101|1697102|1697103|1697104|1697105|1697106|1697107|1697108|1697109|1697110|1697111|1697112|1697113|1697114|1697115|1697116|1697117|1697118|1697119|1697120|1697121|1697122|1697123|1697124|1697125|1835836|1836765|1838623|1839552|1840481|1841410|1842339|1843268|1844197|1889310|1909252|1909253|1909255|1909256|1909257|1909258|1909259|1909272|1909273|1909274|1909275|1909276|1909277|1909278|1909295|1909307|1909308|1909309|1909310|1909311|1909312|1909313|1909314|1909316|1938003|1964060|1990342|2060274,20160223,"001Chemical|10X CHEM|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|AKos Consulting & Solutions|Aladdin Scientific|Amadis Chemical|Ambeed|Angel Pharmatech Ltd.|AppChem|AstaTech, Inc.|Axon Medchem|BenchChem|BindingDB|BioChemPartner|Biosynce Pharmatech|BLD Pharm|BOC Sciences|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|Combi-Blocks|CymitQuimica|DC Chemicals|Debye Scientific Co., Ltd|DTP/NCI|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|InvivoChem|IUPHAR/BPS Guide to PHARMACOLOGY|Key Organics/BIONET|Lan Pharmatech|Mcule|MedChemexpress MCE|Molecule Market|MolGenie|MolPort|Nature Portfolio Journals|NCBI Structure|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|PubChem Reference Collection|RR Scientific|Smolecule|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|TargetMol|Thieme Chemistry",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C185612 - SHP2 Inhibitor
132222602,Jab-3068,"JAB-3068|SHP2-IN-6|JAB3068|2169223-48-5|1-[4-[3-Amino-5-[(4S)-4-amino-2-oxa-8-azaspiro[4.5]decan-8-yl]pyrazin-2-yl]sulfanyl-3,3-difluoro-2H-indol-1-yl]ethanone|ETHANONE, 1-(4-((3-AMINO-5-((4S)-4-AMINO-2-OXA-8-AZASPIRO(4.5)DEC-8-YL)-2-PYRAZINYL)THIO)-3,3-DIFLUORO-2,3-DIHYDRO-1H-INDOL-1-YL)-|Jab 3068|SHP2 Inhibitor JAB-3068|CHEMBL5095185|SCHEMBL19704279|HGYTYZKWKUXRKA-MRXNPFEDSA-N|JAB 3068 [WHO-DD]|JAB-3068 [WHO-DD]|GLXC-26924|V6Q7413SA8|NSC827676|AKOS040757372|NSC-827676|DA-77828|HY-131132|CS-0129188|H26718|(S)-1-(4-(3-amino-5-(4-amino-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-ylthio)-3,3-difluoroindolin-1-yl)ethanone",476.500,C22H26F2N6O2S,136.000,740.000,1.200,33,2,10,3,"InChI=1S/C22H26F2N6O2S/c1-13(31)30-11-22(23,24)18-14(30)3-2-4-15(18)33-20-19(26)28-17(9-27-20)29-7-5-21(6-8-29)12-32-10-16(21)25/h2-4,9,16H,5-8,10-12,25H2,1H3,(H2,26,28)/t16-/m1/s1",CC(=O)N1CC(C2=C1C=CC=C2SC3=NC=C(N=C3N)N4CCC5(CC4)COC[C@H]5N)(F)F,HGYTYZKWKUXRKA-MRXNPFEDSA-N,"1-[4-[3-amino-5-[(4S)-4-amino-2-oxa-8-azaspiro[4.5]decan-8-yl]pyrazin-2-yl]sulfanyl-3,3-difluoro-2H-indol-1-yl]ethanone",476.181,476.181,0,1,0,1,1,0,0,0,0,1,246,83,"",Biological Test Results|Interactions and Pathways|Classification|Drug and Medication Information|Literature|Patents|Associated Disorders and Diseases|Biological Test Results: Active,8,1|3|5|7|9|13|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145,20180129,"10X CHEM|A2B Chem|AbaChemScene|AKos Consulting & Solutions|Amadis Chemical|AstaTech, Inc.|Axon Medchem|ChEMBL|Debye Scientific Co., Ltd|DTP/NCI|ECI Group, LCSB, University of Luxembourg|EvitaChem|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Google Patents|InvivoChem|Key Organics/BIONET|Mcule|MedChemexpress MCE|MolGenie|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|SureChEMBL|SynHet - Synthetic Heterocycles|TargetMol|Thieme Chemistry",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C185612 - SHP2 Inhibitor
134182831,Vociprotafib,"Vociprotafib|RMC-4630|2172652-48-9|RMC4630|SAR442720|SAR-442720|PTPN11 inhibitor RMC-4630|SHP2-IN-7|Vociprotafib [INN]|C4YBF9170L|Rmc 4630|[6-(2-Amino-3-chloropyridin-4-yl)sulfanyl-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl]methanol|RMC 4630 [WHO-DD]|compound A-290 [WO2018013597A1]|2-Pyrazinemethanol, 6-((2-amino-3-chloro-4-pyridinyl)thio)-3-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro(4.5)dec-8-yl)-5-methyl-|2-Pyrazinemethanol, 6-[(2-amino-3-chloro-4-pyridinyl)thio]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]dec-8-yl]-5-methyl-|compound A-290 (WO2018013597A1)|(6-(2-amino-3-chloropyridin-4-yl)sulfanyl-3-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro(4.5)decan-8-yl)-5-methylpyrazin-2-yl)methanol|Vociprotafib (USAN/INN)|VOCIPROTAFIB [USAN]|UNII-C4YBF9170L|SHP2 Inhibitor RMC-4630|CHEMBL5314427|SCHEMBL19785097|GTPL12067|GLXC-25735|EX-A5486|NSC839698|RMC-4630?|AKOS040757388|NSC-839698|SAR 442720|RMC-0694630|DA-68618|MS-28187|HY-141523|CS-0179559|D12799|F82929|(6-((2-Amino-3-chloropyridin-4-yl)sulfanyl)-3-((3S,4S)-4-amino- 3-methyl-2-oxa-8-azaspiro(4.5)decan-8-yl)- 5-methylpyrazin-2-yl)methanol|(6-((2-Amino-3-chloropyridin-4-yl)sulfanyl)-3-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro(4.5)decan-8-yl)-5-methylpyrazin-2-yl)methanol|(6-((2-Amino-3-chloropyridin-4-yl)thio)-3-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-5-methylpyrazin-2-yl)methanol|6-[(2-Amino-3-chloro-4-pyridinyl)thio]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]dec-8-yl]-5-methyl-2-pyrazinemethanol",451.000,C20H27ClN6O2S,149.000,583.000,1.200,30,3,9,4,"InChI=1S/C20H27ClN6O2S/c1-11-19(30-14-3-6-24-17(23)15(14)21)26-13(9-28)18(25-11)27-7-4-20(5-8-27)10-29-12(2)16(20)22/h3,6,12,16,28H,4-5,7-10,22H2,1-2H3,(H2,23,24)/t12-,16+/m0/s1",C[C@H]1[C@H](C2(CCN(CC2)C3=NC(=C(N=C3CO)SC4=C(C(=NC=C4)N)Cl)C)CO1)N,HISJAYUQVHMWTA-BLLLJJGKSA-N,"[6-(2-amino-3-chloropyridin-4-yl)sulfanyl-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl]methanol",450.16,450.16,0,1,0,2,2,0,0,0,0,1,645,173,"",Biological Test Results|Interactions and Pathways|Classification|Drug and Medication Information|Literature|Patents|Associated Disorders and Diseases|Biological Test Results: Active,8,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145,20180623,"10X CHEM|AbaChemScene|AbMole Bioscience|AKos Consulting & Solutions|Amadis Chemical|AstaTech, Inc.|BLD Pharm|ChEMBL|ChemIDplus|CymitQuimica|DC Chemicals|Debye Scientific Co., Ltd|DTP/NCI|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Google Patents|InvivoChem|IUPHAR/BPS Guide to PHARMACOLOGY|KEGG|Key Organics/BIONET|Mcule|MedChemexpress MCE|MolGenie|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|SureChEMBL|SynHet - Synthetic Heterocycles|TargetMol",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C185612 - SHP2 Inhibitor
118239405,Shp2-IN-8,"SHP2-IN-8|CHEMBL4789106|1801692-60-3|6-[4-(aminomethyl)-4-methyl-piperidin-1-yl]-3-[2,3-bis(chloranyl)phenyl]sulfanyl-pyrazin-2-amine|SCHEMBL16915558|GLXC-27271|BDBM50553786|TK-453|DA-77829|HY-144396|CS-0380107|6-(4-(Aminomethyl)-4-methylpiperidin-1-yl)-3-((2,3-dichlorophenyl)thio)pyrazin-2-amine|83Q",398.400,C17H21Cl2N5S,106.000,435.000,3.700,25,2,6,4,"InChI=1S/C17H21Cl2N5S/c1-17(10-20)5-7-24(8-6-17)13-9-22-16(15(21)23-13)25-12-4-2-3-11(18)14(12)19/h2-4,9H,5-8,10,20H2,1H3,(H2,21,23)",CC1(CCN(CC1)C2=CN=C(C(=N2)N)SC3=C(C(=CC=C3)Cl)Cl)CN,HFZSVNQUAOVFHI-UHFFFAOYSA-N,"6-[4-(aminomethyl)-4-methylpiperidin-1-yl]-3-(2,3-dichlorophenyl)sulfanylpyrazin-2-amine",397.089,397.089,0,1,0,0,0,0,0,0,0,3,12,2,"",Biological Test Results|Interactions and Pathways|Classification|Literature|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,7,1697066|1697067|1697069|1697077|1697078|1697079|1697080|1889309|1889310|1889311|1889312|1889313|1889314|1889315|1889316|1889317|1889318|1889319|1889320|1889321|1889322|1889323|1889324|1889325|1889326|1889327|1889328|1889329|1889330|1889331|1889332|1889333,20160223,"AbaChemScene|BindingDB|BLD Pharm|ChEMBL|Debye Scientific Co., Ltd|Glixx Labs Inc|Google Patents|IBM|InvivoChem|MedChemexpress MCE|MolGenie|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|TargetMol",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
134183206,"(3-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-6-(2,3-dichlorophenyl)-5-methylpyrazin-2-yl)methanol","RMC-4550|2172651-73-7|2Q6NVG4EXB|(3-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-6-(2,3-dichlorophenyl)-5-methylpyrazin-2-yl)methanol|[3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-6-(2,3-dichlorophenyl)-5-methylpyrazin-2-yl]methanol|CHEMBL4752026|{3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-6-(2,3-dichlorophenyl)-5-methylpyrazin-2-yl}methanol|RMC-?4550|2-Pyrazinemethanol, 3-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro(4.5)dec-8-yl)-6-(2,3-dichlorophenyl)-5-methyl-|MFCD31746888|UNII-2Q6NVG4EXB|SCHEMBL19785503|RMC-4550 (SHP2 Inhibitor)|GLXC-20197|EX-A3075|XLD65173|BDBM50546219|RMC-4550?|ZB1559|AKOS037648879|AC-31540|BS-15923|DA-57468|HY-116009|CS-0063450|D70060",437.400,C21H26Cl2N4O2,84.500,563.000,2.500,29,2,6,3,"InChI=1S/C21H26Cl2N4O2/c1-12-18(14-4-3-5-15(22)17(14)23)26-16(10-28)20(25-12)27-8-6-21(7-9-27)11-29-13(2)19(21)24/h3-5,13,19,28H,6-11,24H2,1-2H3/t13-,19+/m0/s1",C[C@H]1[C@H](C2(CCN(CC2)C3=NC(=C(N=C3CO)C4=C(C(=CC=C4)Cl)Cl)C)CO1)N,IKUYEYLZXGGCRD-ORAYPTAESA-N,"[3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-6-(2,3-dichlorophenyl)-5-methylpyrazin-2-yl]methanol",436.143,436.143,0,1,0,2,2,0,0,0,0,7,1217,220,"",Biological Test Results|Interactions and Pathways|Classification|Literature|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,7,1674054|1674056|1674057|1674058|1674059|1845964|1845980|1889310|1919327|1919569|1931843|1937999|1956327|1956328|1956329|1956330,20180623,"001Chemical|10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|AbMole Bioscience|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Apexmol|AppChem|AstaTech, Inc.|Axon Medchem|BenchChem|BindingDB|Biosynce Pharmatech|Biosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemShuttle|Combi-Blocks|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Google Patents|Hangzhou APIChem Technology|InvivoChem|J&H Chemical Co.,ltd|Key Organics/BIONET|Lan Pharmatech|LGC Standards|Mcule|MedChemexpress MCE|Molecule Market|MolGenie|MolPort|Nature Portfolio Journals|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Smolecule|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|TargetMol|THE BioTek",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development,""
165412812,Shp2/hdac-IN-1,"SHP2/HDAC-IN-1|CHEMBL5189911|2831230-38-5|BDBM50593162|HY-151464|CS-0613339|4-[[[1-[6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl]-4-methylpiperidin-4-yl]amino]methyl]-N-[[4-[(E)-3-(hydroxyamino)-3-oxoprop-1-enyl]phenyl]methyl]benzamide",660.600,C34H35Cl2N7O3,146.000,1010.000,4.600,46,5,8,10,"InChI=1S/C34H35Cl2N7O3/c1-34(15-17-43(18-16-34)28-21-38-31(32(37)41-28)26-3-2-4-27(35)30(26)36)40-20-24-9-12-25(13-10-24)33(45)39-19-23-7-5-22(6-8-23)11-14-29(44)42-46/h2-14,21,40,46H,15-20H2,1H3,(H2,37,41)(H,39,45)(H,42,44)/b14-11+",CC1(CCN(CC1)C2=CN=C(C(=N2)N)C3=C(C(=CC=C3)Cl)Cl)NCC4=CC=C(C=C4)C(=O)NCC5=CC=C(C=C5)/C=C/C(=O)NO,CJJLAWVMRURPRM-SDNWHVSQSA-N,"4-[[[1-[6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl]-4-methylpiperidin-4-yl]amino]methyl]-N-[[4-[(E)-3-(hydroxyamino)-3-oxoprop-1-enyl]phenyl]methyl]benzamide",659.218,659.218,0,1,0,0,0,0,1,1,0,1,0,0,"",Biological Test Results|Classification|Literature|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,6,1865238|1865239|1865240|1865241|1865242|1865243|1865244|1865245|1865246|1865247|1865248|1865250|1865258|1865259|1865261|1865262|1865263|1865264|1865265|1865266|1865267|1865268|1865269|1865270|1865271|1865272|1865273|1865274|1865275|1865276|1865277|1865278|1865279|1865280|1865281|1865282|1865283|1865284|1865285|1865286|1865287|1865288|1865289|1865290|1865291|1865292|1865295|1865296|1865297|1865298|1865299|1865300|1865301|1865302|1865303|1865304|1865305|1865306|1865307|1865308|1865309|1865310|1865311|1865312,20221102,AbaChemScene|BindingDB|BLD Pharm|ChEMBL|InvivoChem|MedChemexpress MCE|MolGenie|PATENTSCOPE (WIPO)|TargetMol,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
137652273,Shp2-IN-29,"SHP2-IN-29|CHEMBL4075516|Benzoic acid, 2,4-dihydroxy-6-(3E,5E)-3,5-nonadien-1-yl-|BDBM50268487|HY-N12915|BS-1572|CS-1054601|2,4-dihydroxy-6-[(3e,5e)-nona-3,5-dien-1-yl] benzoic acid",276.330,C16H20O4,77.800,348.000,4.500,20,3,4,7,"InChI=1S/C16H20O4/c1-2-3-4-5-6-7-8-9-12-10-13(17)11-14(18)15(12)16(19)20/h4-7,10-11,17-18H,2-3,8-9H2,1H3,(H,19,20)/b5-4+,7-6+",CCC/C=C/C=C/CCC1=C(C(=CC(=C1)O)O)C(=O)O,KTMVZSURHPMBJF-YTXTXJHMSA-N,"2,4-dihydroxy-6-[(3E,5E)-nona-3,5-dienyl]benzoic acid",276.136,276.136,0,1,0,0,0,0,2,2,0,3,0,0,"",Biological Test Results|Classification|Literature|Taxonomy|Biological Test Results: Active|Biological Test Results: Micromolar,6,1486892|1486893|1486894|1486895|1525101,20190408,AbaChemScene|BindingDB|ChEMBL|Key Organics/BIONET|MedChemexpress MCE|MolGenie|Springer Nature|SynHet - Synthetic Heterocycles|TargetMol,Chemical Vendors|Curation Efforts|Journal Publishers|Research and Development,""
164621172,SHP2 degrader ZB-S-29,"CHEMBL4871539|SHP2 degrader ZB-S-29|ZB-S-29|GLXC-26525|BDBM50571445|N1-(3-((3-Amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)-2-chlorophenyl)-N4-(3-(2-(2-(3-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)propoxy)ethoxy)ethoxy)propyl)succinamide",979.500,C46H59ClN10O10S,297.000,1730.000,1.800,68,6,17,23,"InChI=1S/C46H59ClN10O10S/c1-28-40(48)46(27-67-28)14-18-56(19-15-46)34-26-52-43(41(49)54-34)68-33-9-3-8-31(39(33)47)53-36(59)13-12-35(58)51-17-5-21-65-23-25-66-24-22-64-20-4-16-50-30-7-2-6-29-38(30)45(63)57(44(29)62)32-10-11-37(60)55-42(32)61/h2-3,6-9,26,28,32,40,50H,4-5,10-25,27,48H2,1H3,(H2,49,54)(H,51,58)(H,53,59)(H,55,60,61)/t28-,32?,40+/m0/s1",C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C(C(=N3)N)SC4=CC=CC(=C4Cl)NC(=O)CCC(=O)NCCCOCCOCCOCCCNC5=CC=CC6=C5C(=O)N(C6=O)C7CCC(=O)NC7=O)CO1)N,GOEFYTZABOPTQD-PXUBBKKOSA-N,"N'-[3-[3-amino-5-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]pyrazin-2-yl]sulfanyl-2-chlorophenyl]-N-[3-[2-[2-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]ethoxy]ethoxy]propyl]butanediamide",978.382,978.382,0,1,0,3,2,1,0,0,0,2,0,0,"",Biological Test Results|Classification|Literature|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,6,1764584|1764585|1764586|1764587|1764588|1764589|1764590|1764591|1764592|1764593|1764594|1764595|1764596|1764597|1764598|1764599|1764600|1764601|1764602|1764603|1764604|1764605|1764606|1764607|1866111,20220819,BindingDB|ChEMBL|Glixx Labs Inc|MolGenie|Probes & Drugs portal,Chemical Vendors|Curation Efforts|Research and Development,""
146364430,Shp2-IN-31,"SHP2-IN-31|SCHEMBL21703987|BDBM497027|BDBM497074|BDBM608844|BDBM608845|BDBM608891|BDBM608892|IACS-15509|US11001561, Compound 23a|US11001561, Compound 63|US11001561, Compound 63a|US11702392, Compound 23a|US11702392, Compound 23b|US11702392, Compound 63a|US11702392, Compound 63b|BMS-986466|C825F38B80|HY-164427|(3M)-6-[(3S,4S)-4-amino-3- methyl-2-oxa-8- azaspiro[4.5]decan-8-yl]-3-(2,3- dichlorophenyl)-2,5-dimethyl-3,4- dihydropyrimidin-4-one|(3M)-6-[(3S,4S)-4-amino-3- methyl-2-oxa-8- azaspiro[4.5]decan-8-yl]-3-(2,3- dichlorophenyl)-5-(D3)methyl-2- methyl-3,4-dihydropyrimidin-4- one|(3P)-6-[(3S,4S)-4-amino-3- methyl-2-oxa-8- azaspiro[4.5]decan-8-yl]-3-(2,3- dichlorophenyl)-2,5-dimethyl-3,4- dihydropyrimidin-4-one|(3P)-6-[(3S,4S)-4-amino-3- methyl-2-oxa-8- azaspiro[4.5]decan-8-yl]-3-(2,3- dichlorophenyl)-5-(D3)methyl-2- methyl-3,4-dihydropyrimidin-4- one|4(3H)-Pyrimidinone, 6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]dec-8-yl]-3-(2,3-dichlorophenyl)-2,5-dimethyl-",437.400,C21H26Cl2N4O2,71.200,732.000,2.800,29,1,5,2,"InChI=1S/C21H26Cl2N4O2/c1-12-19(26-9-7-21(8-10-26)11-29-13(2)18(21)24)25-14(3)27(20(12)28)16-6-4-5-15(22)17(16)23/h4-6,13,18H,7-11,24H2,1-3H3/t13-,18+/m0/s1",C[C@H]1[C@H](C2(CCN(CC2)C3=C(C(=O)N(C(=N3)C)C4=C(C(=CC=C4)Cl)Cl)C)CO1)N,ABKATOFAZUIEJX-SCLBCKFNSA-N,"6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2,5-dimethylpyrimidin-4-one",436.143,436.143,0,1,0,2,2,0,0,0,0,0,31,7,"",Biological Test Results|Classification|Drug and Medication Information|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,6,1805543|1805891|1919568|1919569|1919570,20200627,BindingDB|FDA Global Substance Registration System (GSRS)|Google Patents|MedChemexpress MCE|MolGenie|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
137796282,SHP2 inhibitor LY6,"SHP2 inhibitor LY6|CHEMBL4435688|2296718-09-5|GLXC-20242|BDBM50531400|DA-77826|HY-125257|CS-0090142|(E)-1-(1-(5-(3-(2,4-Dichlorophenyl)acryloyl)-2-ethoxy-4-hydroxybenzyl)-1,2,5,6-tetrahydropyridin-3-yl)-1H-benzo[d]imidazol-2(3H)-one|3-[1-[[5-[(E)-3-(2,4-dichlorophenyl)prop-2-enoyl]-2-ethoxy-4-hydroxyphenyl]methyl]-3,6-dihydro-2H-pyridin-5-yl]-1H-benzimidazol-2-one",564.500,C30H27Cl2N3O4,82.100,945.000,6.100,39,2,5,8,"InChI=1S/C30H27Cl2N3O4/c1-2-39-29-16-28(37)23(27(36)12-10-19-9-11-21(31)15-24(19)32)14-20(29)17-34-13-5-6-22(18-34)35-26-8-4-3-7-25(26)33-30(35)38/h3-4,6-12,14-16,37H,2,5,13,17-18H2,1H3,(H,33,38)/b12-10+",CCOC1=CC(=C(C=C1CN2CCC=C(C2)N3C4=CC=CC=C4NC3=O)C(=O)/C=C/C5=C(C=C(C=C5)Cl)Cl)O,KXGGLZVQMDYPEO-ZRDIBKRKSA-N,"3-[1-[[5-[(E)-3-(2,4-dichlorophenyl)prop-2-enoyl]-2-ethoxy-4-hydroxyphenyl]methyl]-3,6-dihydro-2H-pyridin-5-yl]-1H-benzimidazol-2-one",563.138,563.138,0,1,0,0,0,0,1,1,0,1,1,1,"",Biological Test Results|Classification|Literature|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,6,1623018|1623019|1623020|1623021|1623022|1623023|1623024|1623025|1623026|1623027|1623028|1623029|1623030|1623031|1623032|1623033|1623034|1623035|1623036|1623037|1623038|1623039|1623040|1623041|1623042|1623043|1623044|1623045|1623046|1623047|1623048|1623049|1623050|1623051|1623052|1623053|1623054|1623055|1623056|1623057|1623058|1623059|1623060|1623061|1623062,20190417,"AbaChemScene|BindingDB|BLD Pharm|ChEMBL|DC Chemicals|Debye Scientific Co., Ltd|Glixx Labs Inc|Google Patents|InvivoChem|MedChemexpress MCE|MolGenie|PATENTSCOPE (WIPO)|TargetMol",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
155930583,"(2S,4R)-1-((S)-2-(9-(4-(4-((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)-4-oxobutanoyl)piperazin-1-yl)nonanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide","SHP2-D26|2458219-65-1|(2S,4R)-1-((S)-2-(9-(4-(4-((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)-4-oxobutanoyl)piperazin-1-yl)nonanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide|PROTAC SHP2 degrader-1|CHEMBL4635440|EX-A9317|AKOS040757791|DA-77159|HY-145162|CS-0368378|EN300-37342684|(2S,4R)-1-[(2S)-2-[9-(4-{3-[(3-{[3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanyl}-2-chlorophenyl)carbamoyl]propanoyl}piperazin-1-yl)nonanamido]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide|(2S,4R)-1-[(2S)-2-[9-[4-[4-[3-[3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanyl-2-chloroanilino]-4-oxobutanoyl]piperazin-1-yl]nonanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide",1115.900,C56H79ClN12O6S2,299.000,1920.000,6.200,77,6,15,23,"InChI=1S/C56H79ClN12O6S2/c1-36(38-17-19-39(20-18-38)49-37(2)61-35-76-49)62-52(74)42-32-40(70)34-69(42)54(75)50(55(3,4)5)65-45(71)16-11-9-7-8-10-12-25-66-28-30-68(31-29-66)47(73)22-21-46(72)63-41-14-13-15-43(48(41)57)77-53-51(58)64-44(33-60-53)67-26-23-56(6,59)24-27-67/h13-15,17-20,33,35-36,40,42,50,70H,7-12,16,21-32,34,59H2,1-6H3,(H2,58,64)(H,62,74)(H,63,72)(H,65,71)/t36-,40+,42-,50+/m0/s1",CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCN4CCN(CC4)C(=O)CCC(=O)NC5=C(C(=CC=C5)SC6=NC=C(N=C6N)N7CCC(CC7)(C)N)Cl)O,XJSPAQRZSJUBLB-WQFCSRJTSA-N,"(2S,4R)-1-[(2S)-2-[9-[4-[4-[3-[3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanyl-2-chloroanilino]-4-oxobutanoyl]piperazin-1-yl]nonanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide",1114.54,1114.54,0,1,0,4,4,0,0,0,0,2,9,5,"",Biological Test Results|Classification|Literature|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,6,1657687|1657689|1657690|1657691|1657692|1657693|1657694|1657695|1657696|1657697|1657698|1657699|1657700|1657701|1657702|1657705|1657707|1657708|1657709|1657710|1657711|1657712,20210716,"10X CHEM|A2B Chem|AbaChemScene|AKos Consulting & Solutions|Amadis Chemical|BLD Pharm|BOC Sciences|ChEMBL|ChemShuttle|Debye Scientific Co., Ltd|Enamine|eNovation Chemicals|Excenen Pharmatech|Google Patents|InvivoChem|Mcule|MedChemexpress MCE|MolGenie|MolPort|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|Probes & Drugs portal|TargetMol|Thieme Chemistry",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development|Subscription Services,""
162641701,SHP2 protein degrader-1,SHP2 protein degrader-1|2624181-69-5|CHEMBL5190061|PROTAC SP4|SHP2-targeting PROTAC SP4|GLXC-26524|BDBM50593516|AKOS040757910|DA-77827|HY-145159|CS-0356862,908.800,C42H51Cl2N11O8,230.000,1520.000,2.200,63,4,16,22,"InChI=1S/C42H51Cl2N11O8/c1-42(10-13-53(14-11-42)33-25-47-37(38(45)49-33)29-5-2-6-30(43)36(29)44)48-24-27-26-54(52-51-27)15-17-61-19-21-63-23-22-62-20-18-60-16-12-46-31-7-3-4-28-35(31)41(59)55(40(28)58)32-8-9-34(56)50-39(32)57/h2-7,25-26,32,46,48H,8-24H2,1H3,(H2,45,49)(H,50,56,57)",CC1(CCN(CC1)C2=CN=C(C(=N2)N)C3=C(C(=CC=C3)Cl)Cl)NCC4=CN(N=N4)CCOCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C6=O)C7CCC(=O)NC7=O,PVZCLGQITBYVPH-UHFFFAOYSA-N,"4-[2-[2-[2-[2-[2-[4-[[[1-[6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl]-4-methylpiperidin-4-yl]amino]methyl]triazol-1-yl]ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione",907.33,907.33,0,1,0,1,0,1,0,0,0,1,0,0,"",Biological Test Results|Classification|Literature|Biological Test Results: Active|Biological Test Results: Micromolar,5,1866110,20220315,"AbaChemScene|AKos Consulting & Solutions|BindingDB|BOC Sciences|ChEMBL|Debye Scientific Co., Ltd|Glixx Labs Inc|InvivoChem|MedChemexpress MCE|MolGenie|Probes & Drugs portal|TargetMol",Chemical Vendors|Curation Efforts|Research and Development,""
164887497,Shp2/cdk4-IN-1,SHP2/CDK4-IN-1|CHEMBL5179617|BDBM50605448|HY-150609|CS-0534860|2924036-87-1,693.200,C33H35ClF2N10OS,158.000,1080.000,5.000,48,2,13,7,"InChI=1S/C33H35ClF2N10OS/c1-17(2)46-19(4)42-29-21(35)11-20(12-23(29)46)28-22(36)13-41-32(43-28)44-31-27(34)24(5-8-38-31)48-26-15-39-25(14-40-26)45-9-6-33(7-10-45)16-47-18(3)30(33)37/h5,8,11-15,17-18,30H,6-7,9-10,16,37H2,1-4H3,(H,38,41,43,44)/t18-,30+/m0/s1",C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C(C=N3)SC4=C(C(=NC=C4)NC5=NC=C(C(=N5)C6=CC7=C(C(=C6)F)N=C(N7C(C)C)C)F)Cl)CO1)N,ZDEBEWQYXJZQRS-YVGXBJCXSA-N,"(3S,4S)-8-[5-[3-chloro-2-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]pyridin-4-yl]sulfanylpyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine",692.237,692.237,0,1,0,2,2,0,0,0,0,1,0,0,"",Biological Test Results|Classification|Literature|Biological Test Results: Active|Biological Test Results: Micromolar,5,1909253|1909254|1909255|1909256|1909258|1909260|1909261|1909262|1909263|1909264|1909265|1909266|1909267|1909268|1909269|1909270|1909271|1909272|1909273|1909274|1909275|1909276|1909277|1909278|1909279|1909280|1909281|1909282|1909283|1909284|1909285|1909286|1909287|1909288|1909289|1909290|1909291|1909292|1909293|1909294|1909295|1909296|1909297|1909298|1909299|1909300|1909301|1909302|1909303|1909304|1909305|1909306|1909317|1909318|1909319|1909320|1909321|1909322|1909323|1909324,20220905,AbaChemScene|BindingDB|BLD Pharm|ChEMBL|MedChemexpress MCE|MolGenie|TargetMol,Chemical Vendors|Curation Efforts|Research and Development,""
118247742,Shp2 IN-1,"SHP2 IN-1|1801764-90-8|SHP2-IN-1|SCHEMBL16925047|BDBM408072|US10336774, Example 57|AKOS040738125|DA-57844|HY-114460|CS-0086092|(2S,4R)-4-amino-8-[6-amino-5-(2,3-dichloropyridin-4-yl)sulfanylpyrazin-2-yl]-8-azaspiro[4.5]decan-2-ol",441.400,C18H22Cl2N6OS,139.000,540.000,2.400,28,3,8,3,"InChI=1S/C18H22Cl2N6OS/c19-14-11(1-4-23-15(14)20)28-17-16(22)25-13(9-24-17)26-5-2-18(3-6-26)8-10(27)7-12(18)21/h1,4,9-10,12,27H,2-3,5-8,21H2,(H2,22,25)/t10-,12-/m1/s1",C1CN(CCC12C[C@@H](C[C@H]2N)O)C3=CN=C(C(=N3)N)SC4=C(C(=NC=C4)Cl)Cl,VCACXGULTWUFOL-ZYHUDNBSSA-N,"(2S,4R)-4-amino-8-[6-amino-5-(2,3-dichloropyridin-4-yl)sulfanylpyrazin-2-yl]-8-azaspiro[4.5]decan-2-ol",440.095,440.095,0,1,0,2,2,0,0,0,0,0,30,3,"",Biological Test Results|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,4,1803712|1964060,20160223,"AbaChemScene|AKos Consulting & Solutions|BindingDB|DC Chemicals|Debye Scientific Co., Ltd|Google Patents|InvivoChem|Mcule|MedChemexpress MCE|Novartis Institutes for BioMedical Research|PATENTSCOPE (WIPO)|Probes & Drugs portal|SureChEMBL|TargetMol",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
156805720,Shp2-IN-14,"SHP2-IN-14|SCHEMBL26633608|BDBM633171|US20230348467, Compound 27|HY-153699|CS-0835117|2673400-91-2",483.300,C22H20Cl2N8O,140.000,702.000,2.900,33,3,7,4,"InChI=1S/C22H20Cl2N8O/c23-15-13(6-9-27-18(15)24)16-14-17(19(25)33)28-21(29-20(14)31-30-16)32-10-7-22(26,8-11-32)12-4-2-1-3-5-12/h1-6,9H,7-8,10-11,26H2,(H2,25,33)(H,28,29,30,31)",C1CN(CCC1(C2=CC=CC=C2)N)C3=NC4=NNC(=C4C(=N3)C(=O)N)C5=C(C(=NC=C5)Cl)Cl,KVYQUJXENRXDEN-UHFFFAOYSA-N,"6-(4-amino-4-phenylpiperidin-1-yl)-3-(2,3-dichloropyridin-4-yl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide",482.114,482.114,0,1,0,0,0,0,0,0,0,0,7,1,"",Biological Test Results|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,4,1919962,20211110,AbaChemScene|BindingDB|BLD Pharm|Google Patents|MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
156245410,Shp2-IN-27,"SHP2-IN-27|SCHEMBL23208776|SCHEMBL23208838|US11466016, Example 2|US11466016, Example 3|BDBM575871|BDBM575873|HY-162355|CS-1012397|endo-8-[7-(4- chloro-2- methyl-2H- indazol-5-yl)- 5H-pyrrolo[2,3- b]pyrazin-3-yl]-8- azabicyclo[3.2.1] octan-3-amine|exo-8-[7-(4- chloro-2- methyl-2H- indazol-5-yl)- 5H-pyrrolo[2,3- b]pyrazin-3-yl]- 8-azabicyclo [3.2.1]octan- 3-amine",407.900,C21H22ClN7,88.700,608.000,2.900,29,2,5,2,"InChI=1S/C21H22ClN7/c1-28-10-16-17(27-28)5-4-14(19(16)22)15-8-25-21-20(15)24-9-18(26-21)29-12-2-3-13(29)7-11(23)6-12/h4-5,8-13H,2-3,6-7,23H2,1H3,(H,25,26)/t11?,12-,13+",CN1C=C2C(=N1)C=CC(=C2Cl)C3=CNC4=NC(=CN=C34)N5[C@@H]6CC[C@H]5CC(C6)N,XRNTZAQBJAFMBB-YHWZYXNKSA-N,"(1S,5R)-8-[7-(4-chloro-2-methylindazol-5-yl)-5H-pyrrolo[2,3-b]pyrazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine",407.163,407.163,0,1,0,2,2,0,0,0,0,0,11,1,"",Biological Test Results|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,4,1806881,20210821,AbaChemScene|BindingDB|Google Patents|MedChemexpress MCE|NCBI Structure|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
164860248,SHP2 Inhibitor 25,"CHEMBL5290261|SHP2 Inhibitor 25|SCHEMBL26921381|SCHEMBL26921394|GLXC-27270|BDBM50615006|((1R,5S,6r)-3-(3-(4-Chloro-2-methyl-2H-indazol-5-yl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-6-(4-methylthiazol-2-yl)-3-azabicyclo[3.1.0]hexan-6-yl)methanamine",492.000,C23H22ClN9S,143.000,780.000,2.600,34,2,8,4,"InChI=1S/C23H22ClN9S/c1-11-9-34-22(27-11)23(10-25)14-7-33(8-15(14)23)17-5-26-20-19(29-30-21(20)28-17)12-3-4-16-13(18(12)24)6-32(2)31-16/h3-6,9,14-15H,7-8,10,25H2,1-2H3,(H,28,29,30)/t14-,15+,23?",CC1=CSC(=N1)C2([C@H]3[C@@H]2CN(C3)C4=NC5=NNC(=C5N=C4)C6=C(C7=CN(N=C7C=C6)C)Cl)CN,NTWGWRIHHGNWMJ-VGVWNIBESA-N,"[(1R,5S)-3-[3-(4-chloro-2-methylindazol-5-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-6-(4-methyl-1,3-thiazol-2-yl)-3-azabicyclo[3.1.0]hexan-6-yl]methanamine",491.141,491.141,0,1,0,2,2,0,0,0,0,1,1,1,"",Biological Test Results|Classification|Literature|Patents,4,1956327|1956328|1956329|1956330|1956332|1956333|1956334|1956335|1956336|1956337|1956338|1956339|1956340|1956341|1956342|1956343|1956344|1956345|1956346|1963568,20220827,BindingDB|ChEMBL|Glixx Labs Inc|MolGenie|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
2865111,"1-(2-methyl-4,5-disulfophenyl)-5-oxo-4,5-dihydro-1H-pyrazole-3-carboxylic acid","SHP2 Inhibitor C21|1-(2-methyl-4,5-disulfophenyl)-5-oxo-4,5-dihydro-1H-pyrazole-3-carboxylic acid|293327-21-6|1-(2-methyl-4,5-disulfophenyl)-5-oxo-4H-pyrazole-3-carboxylic acid|STK396413|AKOS004912548",378.300,C11H10N2O9S2,195.000,790.000,-1.200,24,3,10,4,"InChI=1S/C11H10N2O9S2/c1-5-2-8(23(17,18)19)9(24(20,21)22)4-7(5)13-10(14)3-6(12-13)11(15)16/h2,4H,3H2,1H3,(H,15,16)(H,17,18,19)(H,20,21,22)",CC1=CC(=C(C=C1N2C(=O)CC(=N2)C(=O)O)S(=O)(=O)O)S(=O)(=O)O,SEYODHVKSAPCBO-UHFFFAOYSA-N,"1-(2-methyl-4,5-disulfophenyl)-5-oxo-4H-pyrazole-3-carboxylic acid",377.983,377.983,0,1,0,0,0,0,0,0,0,1,0,0,"",Biological Test Results|Classification|Literature|Biological Test Results: Active,4,607503|607504|607505|607506|607508|607509|607510|607511|607512|607513|607514|607515|607516|607517|607543|607544|607545|607546|607547|607548|607549,20050729,ABI Chem|AKos Consulting & Solutions|Ambinter|Angene Chemical|ASINEX|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|Chem-Space.com Database|ChEMBL|ChemBridge|ChemDB|ChemSpider|DiscoveryGate|Glixx Labs Inc|Matrix Scientific|Mcule|MolGenie|MolPort|MuseChem|NextBio|Smolecule|THE BioTek|Thomson Pharma|TimTec|Vitas-M Laboratory|ZINC,Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
146485511,Shp2-IN-23,SHP2-IN-23|CHEMBL5431126|SCHEMBL21855847|BDBM50634617|HY-149759|CS-0907229,491.000,C24H23ClN8S,145.000,708.000,2.700,34,2,9,3,"InChI=1S/C24H23ClN8S/c25-20-17(5-9-29-22(20)27)34-19-4-3-15-23(32-19)30-13-18(31-15)33-10-6-24(7-11-33)12-16-14(21(24)26)2-1-8-28-16/h1-5,8-9,13,21H,6-7,10-12,26H2,(H2,27,29)/t21-/m1/s1",C1CN(CCC12CC3=C([C@H]2N)C=CC=N3)C4=CN=C5C(=N4)C=CC(=N5)SC6=C(C(=NC=C6)N)Cl,BWQAQACZKDLJAW-OAQYLSRUSA-N,"(5S)-1'-[6-(2-amino-3-chloropyridin-4-yl)sulfanylpyrido[2,3-b]pyrazin-2-yl]spiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine",490.145,490.145,0,1,0,1,1,0,0,0,0,0,14,1,"",Biological Test Results|Classification|Patents,3,2039006|2039007|2039008|2039009|2039010|2039011|2039012|2039013|2039014|2039015|2039016|2039017|2039018|2039019|2039020|2039022|2039023|2039024|2039025|2039026|2039027|2039028,20200627,AbaChemScene|BindingDB|ChEMBL|Google Patents|MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
169450651,Shp2-IN-17,SHP2-IN-17|CHEMBL5402432|SCHEMBL25346756|BDBM50629515|HY-155273|CS-0896496,479.400,C25H24Cl2N6,72.300,702.000,4.000,33,1,5,2,"InChI=1S/C25H24Cl2N6/c1-15-22(17-4-2-6-18(26)21(17)27)33-20(7-11-30-33)24(31-15)32-12-8-25(9-13-32)14-19-16(23(25)28)5-3-10-29-19/h2-7,10-11,23H,8-9,12-14,28H2,1H3/t23-/m1/s1",CC1=C(N2C(=CC=N2)C(=N1)N3CCC4(CC3)CC5=C([C@H]4N)C=CC=N5)C6=C(C(=CC=C6)Cl)Cl,VDHSTSPBTMNKLI-HSZRJFAPSA-N,"(5S)-1'-[7-(2,3-dichlorophenyl)-6-methylpyrazolo[1,5-a]pyrazin-4-yl]spiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine",478.144,478.144,0,1,0,1,1,0,0,0,0,0,2,2,"",Biological Test Results|Classification|Patents,3,2016784,20231214,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE|SureChEMBL|TargetMol,Chemical Vendors|Curation Efforts|Research and Development,""
169450652,Shp2-IN-18,SHP2-IN-18|CHEMBL5402623|SCHEMBL25346562|BDBM50629514|HY-155274|CS-0896567,442.500,C26H27FN6,72.300,698.000,3.200,33,1,6,2,"InChI=1S/C26H27FN6/c1-16-5-6-18(20(27)14-16)23-17(2)31-25(22-7-11-30-33(22)23)32-12-8-26(9-13-32)15-21-19(24(26)28)4-3-10-29-21/h3-7,10-11,14,24H,8-9,12-13,15,28H2,1-2H3/t24-/m1/s1",CC1=CC(=C(C=C1)C2=C(N=C(C3=CC=NN32)N4CCC5(CC4)CC6=C([C@H]5N)C=CC=N6)C)F,LHBBGNUOZGONQB-XMMPIXPASA-N,"(5S)-1'-[7-(2-fluoro-4-methylphenyl)-6-methylpyrazolo[1,5-a]pyrazin-4-yl]spiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine",442.228,442.228,0,1,0,1,1,0,0,0,0,0,2,2,"",Biological Test Results|Classification|Patents,3,2016784,20231214,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE|SureChEMBL|TargetMol,Chemical Vendors|Curation Efforts|Research and Development,""
168944389,Shp2-IN-21,SHP2-IN-21|CHEMBL5423545|SCHEMBL25346678|BDBM50629517|HY-155277|CS-0896688|2941499-08-5,467.500,C27H26FN7,88.100,775.000,2.900,35,2,6,2,"InChI=1S/C27H26FN7/c1-16-24(19-4-5-20(28)17-6-11-31-23(17)19)35-22(7-12-32-35)26(33-16)34-13-8-27(9-14-34)15-21-18(25(27)29)3-2-10-30-21/h2-7,10-12,25,31H,8-9,13-15,29H2,1H3/t25-/m1/s1",CC1=C(N2C(=CC=N2)C(=N1)N3CCC4(CC3)CC5=C([C@H]4N)C=CC=N5)C6=C7C(=C(C=C6)F)C=CN7,TXYIIUMBLYKJPV-RUZDIDTESA-N,"(5S)-1'-[7-(4-fluoro-1H-indol-7-yl)-6-methylpyrazolo[1,5-a]pyrazin-4-yl]spiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine",467.223,467.223,0,1,0,1,1,0,0,0,0,0,2,2,"",Biological Test Results|Classification|Patents,3,2016784,20231109,AbaChemScene|BindingDB|BLD Pharm|ChEMBL|MedChemexpress MCE|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
169450655,Shp2-IN-20,SHP2-IN-20|CHEMBL5411170|SCHEMBL25346479|EX-A8691|BDBM50629516|HY-155276|CS-0896648,446.500,C25H24F2N6,72.300,702.000,2.900,33,1,7,2,"InChI=1S/C25H24F2N6/c1-15-22(17-5-4-16(26)13-19(17)27)33-21(6-10-30-33)24(31-15)32-11-7-25(8-12-32)14-20-18(23(25)28)3-2-9-29-20/h2-6,9-10,13,23H,7-8,11-12,14,28H2,1H3/t23-/m1/s1",CC1=C(N2C(=CC=N2)C(=N1)N3CCC4(CC3)CC5=C([C@H]4N)C=CC=N5)C6=C(C=C(C=C6)F)F,SNLILQPOOHTROO-HSZRJFAPSA-N,"(5S)-1'-[7-(2,4-difluorophenyl)-6-methylpyrazolo[1,5-a]pyrazin-4-yl]spiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine",446.203,446.203,0,1,0,1,1,0,0,0,0,0,2,2,"",Biological Test Results|Classification|Patents,3,2016784,20231214,AbaChemScene|BindingDB|ChEMBL|Excenen Pharmatech|MedChemexpress MCE|SureChEMBL|TargetMol,Chemical Vendors|Curation Efforts|Research and Development,""
169450653,Shp2-IN-19,SHP2-IN-19|CHEMBL5397998|SCHEMBL25345670|BDBM50629513|HY-155275|CS-0896601|2941498-84-4,468.500,C27H28N6O2,90.800,762.000,2.400,35,1,7,2,"InChI=1S/C27H28N6O2/c1-17-24(18-4-5-22-23(15-18)35-14-13-34-22)33-21(6-10-30-33)26(31-17)32-11-7-27(8-12-32)16-20-19(25(27)28)3-2-9-29-20/h2-6,9-10,15,25H,7-8,11-14,16,28H2,1H3/t25-/m1/s1",CC1=C(N2C(=CC=N2)C(=N1)N3CCC4(CC3)CC5=C([C@H]4N)C=CC=N5)C6=CC7=C(C=C6)OCCO7,XQGWBLQMOKYLFS-RUZDIDTESA-N,"(5S)-1'-[7-(2,3-dihydro-1,4-benzodioxin-6-yl)-6-methylpyrazolo[1,5-a]pyrazin-4-yl]spiro[5,7-dihydrocyclopenta[b]pyridine-6,4'-piperidine]-5-amine",468.227,468.227,0,1,0,1,1,0,0,0,0,0,2,2,"",Biological Test Results|Classification|Patents,3,2016784,20231214,AbaChemScene|BindingDB|BLD Pharm|ChEMBL|MedChemexpress MCE|SureChEMBL|TargetMol,Chemical Vendors|Curation Efforts|Research and Development,""
169450050,Shp2-IN-16,SHP2-IN-16|CHEMBL5412259|SCHEMBL25421519|BDBM50629518|HY-155272|CS-0896495,462.500,C25H24F2N6O,88.600,887.000,1.800,34,2,7,2,"InChI=1S/C25H24F2N6O/c1-14-22(16-3-2-4-17(26)21(16)27)33-19(7-10-29-33)24(30-14)32-11-8-25(9-12-32)13-18-15(23(25)28)5-6-20(34)31-18/h2-7,10,23H,8-9,11-13,28H2,1H3,(H,31,34)/t23-/m1/s1",CC1=C(N2C(=CC=N2)C(=N1)N3CCC4(CC3)CC5=C([C@H]4N)C=CC(=O)N5)C6=C(C(=CC=C6)F)F,YPAIQYUKPJORDA-HSZRJFAPSA-N,"(5S)-5-amino-1'-[7-(2,3-difluorophenyl)-6-methylpyrazolo[1,5-a]pyrazin-4-yl]spiro[5,7-dihydro-1H-cyclopenta[b]pyridine-6,4'-piperidine]-2-one",462.198,462.198,0,1,0,1,1,0,0,0,0,0,2,2,"",Biological Test Results|Classification|Patents,3,2016784,20231214,AbaChemScene|BindingDB|ChEMBL|MedChemexpress MCE|SureChEMBL,Chemical Vendors|Curation Efforts|Research and Development,""
169450675,Shp2-IN-22,SHP2-IN-22|CHEMBL5428525|EX-A8692|BDBM50629327|HY-149607|CS-0898300|2802453-88-7,497.400,C23H22Cl2N8O,130.000,754.000,3.000,34,2,7,5,"InChI=1S/C23H22Cl2N8O/c1-34-18-11-15(6-5-14(18)12-26)30-23(28)33-9-7-32(8-10-33)19-13-29-21(22(27)31-19)16-3-2-4-17(24)20(16)25/h2-6,11,13H,7-10H2,1H3,(H2,27,31)(H2,28,30)",COC1=C(C=CC(=C1)N=C(N)N2CCN(CC2)C3=CN=C(C(=N3)N)C4=C(C(=CC=C4)Cl)Cl)C#N,MZIJBZJSXSVRKO-UHFFFAOYSA-N,"4-[6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl]-N'-(4-cyano-3-methoxyphenyl)piperazine-1-carboximidamide",496.129,496.129,0,1,0,0,0,0,0,0,0,0,0,0,"",Biological Test Results|Classification,2,2016075|2016076|2016077|2016078|2016079|2016080|2016081|2016082|2016083|2016084|2016085|2016086|2016088|2016089|2016090|2016091|2016092|2016093|2016094|2016095|2016096|2016097|2016098|2016099|2016100|2016101|2016102|2016103|2016105|2016106|2016107|2016108|2016109|2016110|2016111|2016112|2016113|2016114|2016115|2016116|2016117|2016118|2016119|2016120|2016121,20231214,AbaChemScene|BindingDB|ChEMBL|Excenen Pharmatech|MedChemexpress MCE|TargetMol,Chemical Vendors|Curation Efforts|Research and Development,""
153273978,Shp2-IN-5,"SHP2-IN-5|SCHEMBL22678668|PD002182|HY-130631|CS-0109813|3,4,6-Trihydroxy-5-oxo-5H-benzo[7]annulene-8-carboxylic acid|54755-93-0",248.190,C12H8O6,115.000,449.000,1.700,18,4,6,1,"InChI=1S/C12H8O6/c13-7-2-1-5-3-6(12(17)18)4-8(14)11(16)9(5)10(7)15/h1-4,13,15H,(H,14,16)(H,17,18)",C1=CC(=C(C2=C1C=C(C=C(C2=O)O)C(=O)O)O)O,XCSLJQFPTAZKDV-UHFFFAOYSA-N,"3,4,6-trihydroxy-5-oxobenzo[7]annulene-8-carboxylic acid",248.032,248.032,0,1,0,0,0,0,0,0,0,0,34,12,"",Classification|Patents,2,"",20200813,AbaChemScene|BLD Pharm|Cheminformatics Friedrich-Schiller-University Jena|Google Patents|MedChemexpress MCE|MolGenie|Probes & Drugs portal|SureChEMBL,Chemical Vendors|Curation Efforts|Research and Development,""
129222067,SHP2 inhibitor CNBDA,"SHP2 inhibitor CNBDA|CHEMBL5412721|SCHEMBL18958879|GLXC-27274|2101321-90-6|4,4'-(4'-Carboxy-4-(nonyloxy)-[1,1'-biphenyl]-3,5-diyl)dibutyric acid",512.600,C30H40O7,121.000,641.000,7.200,37,3,7,19,"InChI=1S/C30H40O7/c1-2-3-4-5-6-7-8-19-37-29-24(11-9-13-27(31)32)20-26(21-25(29)12-10-14-28(33)34)22-15-17-23(18-16-22)30(35)36/h15-18,20-21H,2-14,19H2,1H3,(H,31,32)(H,33,34)(H,35,36)",CCCCCCCCCOC1=C(C=C(C=C1CCCC(=O)O)C2=CC=C(C=C2)C(=O)O)CCCC(=O)O,GLVGBEAYRNBVMW-UHFFFAOYSA-N,"4-[3,5-bis(3-carboxypropyl)-4-nonoxyphenyl]benzoic acid",512.277,512.277,0,1,0,0,0,0,0,0,0,0,2,1,"",Biological Test Results|Patents,2,1994322,20170804,Amadis Chemical|ChEMBL|Glixx Labs Inc|SureChEMBL,Chemical Vendors|Curation Efforts|Research and Development,""
168355517,Shp2-IN-13,SHP2-IN-13|CHEMBL5440998|BDBM50626861|HY-149241|CS-0738019|2951854-02-5,327.380,C16H21N7O,123.000,438.000,0.400,24,3,7,3,"InChI=1S/C16H21N7O/c1-16(18)4-7-23(8-5-16)15-20-10-12(13(17)22-15)14(24)21-11-3-2-6-19-9-11/h2-3,6,9-10H,4-5,7-8,18H2,1H3,(H,21,24)(H2,17,20,22)",CC1(CCN(CC1)C2=NC=C(C(=N2)N)C(=O)NC3=CN=CC=C3)N,HFSPLSHISPIUQQ-UHFFFAOYSA-N,4-amino-2-(4-amino-4-methylpiperidin-1-yl)-N-pyridin-3-ylpyrimidine-5-carboxamide,327.181,327.181,0,1,0,0,0,0,0,0,0,0,0,0,"",Biological Test Results|Classification,2,2009144|2009148|2009149|2009150|2009151|2009152|2009153|2009154|2009155|2009156|2009157|2009158|2009159|2009160|2009161|2009162|2009163|2009164|2009165|2009166|2009167|2009168|2009169|2009170|2009171|2009172|2009173|2009174|2009175|2009176|2009177|2009178|2009179|2009180|2009181|2009182|2009183|2009184|2009185,20230706,AbaChemScene|BindingDB|BLD Pharm|ChEMBL|MedChemexpress MCE|Probes & Drugs portal|TargetMol,Chemical Vendors|Curation Efforts|Research and Development,""
162640809,SHP2-IN-6 (hydrochloride),"SHP2-IN-6 (hydrochloride)|SHP2-IN-6 HYDROCHLORIDE|2169223-49-6|1-[4-[3-amino-5-[(4S)-4-amino-2-oxa-8-azaspiro[4.5]decan-8-yl]pyrazin-2-yl]sulfanyl-3,3-difluoro-2H-indol-1-yl]ethanone;hydrochloride|AKOS040757373|HY-131132A|MS-29523|CS-0136889|F82756",513.000,C22H27ClF2N6O2S,136.000,740.000,"",34,3,10,3,"InChI=1S/C22H26F2N6O2S.ClH/c1-13(31)30-11-22(23,24)18-14(30)3-2-4-15(18)33-20-19(26)28-17(9-27-20)29-7-5-21(6-8-29)12-32-10-16(21)25;/h2-4,9,16H,5-8,10-12,25H2,1H3,(H2,26,28);1H/t16-;/m1./s1",CC(=O)N1CC(C2=C1C=CC=C2SC3=NC=C(N=C3N)N4CCC5(CC4)COC[C@H]5N)(F)F.Cl,CVTYVQDHPFFBBF-PKLMIRHRSA-N,"1-[4-[3-amino-5-[(4S)-4-amino-2-oxa-8-azaspiro[4.5]decan-8-yl]pyrazin-2-yl]sulfanyl-3,3-difluoro-2H-indol-1-yl]ethanone;hydrochloride",512.157,512.157,0,2,0,1,1,0,0,0,0,0,0,0,"",Classification,1,"",20220315,"10X CHEM|A2B Chem|AbaChemScene|AKos Consulting & Solutions|Amadis Chemical|AstaTech, Inc.|EvitaChem|InvivoChem|Key Organics/BIONET|Mcule|MedChemexpress MCE|MolPort|Probes & Drugs portal|SynHet - Synthetic Heterocycles",Chemical Vendors|Research and Development,""
163408836,SHP2 protein degrader-2,"SHP2 protein degrader-2|2740582-16-3|SCHEMBL25885133|DA-57845|HY-145703|CS-0379498|EN300-44826050|(2R,4S)-1-[(2R)-2-[9-(4-{3-[(3-{[3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanyl}-2-chlorophenyl)carbamoyl]propanoyl}piperazin-1-yl)nonanamido]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1R)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide|(2R,4S)-1-[(2R)-2-[9-[4-[4-[3-[3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanyl-2-chloroanilino]-4-oxobutanoyl]piperazin-1-yl]nonanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1R)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide",1115.900,C56H79ClN12O6S2,299.000,1920.000,6.200,77,6,15,23,"InChI=1S/C56H79ClN12O6S2/c1-36(38-17-19-39(20-18-38)49-37(2)61-35-76-49)62-52(74)42-32-40(70)34-69(42)54(75)50(55(3,4)5)65-45(71)16-11-9-7-8-10-12-25-66-28-30-68(31-29-66)47(73)22-21-46(72)63-41-14-13-15-43(48(41)57)77-53-51(58)64-44(33-60-53)67-26-23-56(6,59)24-27-67/h13-15,17-20,33,35-36,40,42,50,70H,7-12,16,21-32,34,59H2,1-6H3,(H2,58,64)(H,62,74)(H,63,72)(H,65,71)/t36-,40+,42-,50+/m1/s1",CC1=C(SC=N1)C2=CC=C(C=C2)[C@@H](C)NC(=O)[C@H]3C[C@@H](CN3C(=O)[C@@H](C(C)(C)C)NC(=O)CCCCCCCCN4CCN(CC4)C(=O)CCC(=O)NC5=C(C(=CC=C5)SC6=NC=C(N=C6N)N7CCC(CC7)(C)N)Cl)O,XJSPAQRZSJUBLB-ISSNAGQGSA-N,"(2R,4S)-1-[(2R)-2-[9-[4-[4-[3-[3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanyl-2-chloroanilino]-4-oxobutanoyl]piperazin-1-yl]nonanoylamino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1R)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide",1114.54,1114.54,0,1,0,4,4,0,0,0,0,0,1,1,"",Patents,1,"",20220630,"10X CHEM|A2B Chem|AbaChemScene|Amadis Chemical|Debye Scientific Co., Ltd|Enamine|eNovation Chemicals|InvivoChem|Mcule|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|SureChEMBL|TargetMol",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
171037888,Shp2-IN-25,SHP2-IN-25|HY-162233|CS-0998536,471.500,C22H20F3N7S,117.000,636.000,4.100,33,3,10,6,"InChI=1S/C22H20F3N7S/c23-22(24,25)18-16(7-4-8-26-18)33-17-12-28-19-20(30-17)32-21(31-19)29-11-13-9-15(27-10-13)14-5-2-1-3-6-14/h1-8,12-13,15,27H,9-11H2,(H2,28,29,30,31,32)/t13-,15+/m1/s1",C1[C@H](CN[C@@H]1C2=CC=CC=C2)CNC3=NC4=NC=C(N=C4N3)SC5=C(N=CC=C5)C(F)(F)F,RZNLHKIZYUAZEQ-HIFRSBDPSA-N,"N-[[(3R,5S)-5-phenylpyrrolidin-3-yl]methyl]-5-[2-(trifluoromethyl)pyridin-3-yl]sulfanyl-3H-imidazo[4,5-b]pyrazin-2-amine",471.145,471.145,0,1,0,2,2,0,0,0,0,0,0,0,"",Classification,1,"",20240403,AbaChemScene|MedChemexpress MCE,Chemical Vendors,""
163321912,Shp2-IN-9,SHP2-IN-9|EX-A8690|HY-115925|CS-0433763|2987135-92-0,385.500,C20H20FN3O2S,90.000,594.000,3.600,27,1,5,4,"InChI=1S/C20H20FN3O2S/c21-14-8-6-13(7-9-14)10-22-17(25)11-24-12-23-19-18(20(24)26)15-4-2-1-3-5-16(15)27-19/h6-9,12H,1-5,10-11H2,(H,22,25)",C1CCC2=C(CC1)SC3=C2C(=O)N(C=N3)CC(=O)NCC4=CC=C(C=C4)F,XMJVKWKUTXOIKU-UHFFFAOYSA-N,"N-[(4-fluorophenyl)methyl]-2-(3-oxo-8-thia-4,6-diazatricyclo[7.5.0.02,7]tetradeca-1(9),2(7),5-trien-4-yl)acetamide",385.126,385.126,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification,1,"",20220602,10X CHEM|AbaChemScene|BLD Pharm|Excenen Pharmatech|Mcule|MedChemexpress MCE|MolPort|Probes & Drugs portal,Chemical Vendors|Research and Development,""
172677397,Shp2-IN-34,SHP2-IN-34|HY-169918,518.500,C23H25Cl2N7OS,147.000,684.000,3.900,34,4,7,5,"InChI=1S/C23H25Cl2N7OS/c1-23(27)8-10-32(11-9-23)18-13-28-21(20(26)31-18)34-17-7-3-6-16(19(17)25)30-22(33)29-15-5-2-4-14(24)12-15/h2-7,12-13H,8-11,27H2,1H3,(H2,26,31)(H2,29,30,33)",CC1(CCN(CC1)C2=CN=C(C(=N2)N)SC3=CC=CC(=C3Cl)NC(=O)NC4=CC(=CC=C4)Cl)N,REDIXOPSFHVTOY-UHFFFAOYSA-N,1-[3-[3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl]sulfanyl-2-chlorophenyl]-3-(3-chlorophenyl)urea,517.122,517.122,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20250307,MedChemexpress MCE,Chemical Vendors,""
170453279,Shp2-IN-24,SHP2-IN-24|HY-157535|CS-0978895,500.000,C23H22ClN5O4S,147.000,706.000,4.500,34,3,7,10,"InChI=1S/C23H22ClN5O4S/c1-32-19-8-7-14(24)10-16(19)21-27-23(29-28-21)34-12-20(30)26-18(22(31)33-2)9-13-11-25-17-6-4-3-5-15(13)17/h3-8,10-11,18,25H,9,12H2,1-2H3,(H,26,30)(H,27,28,29)/t18-/m1/s1",COC1=C(C=C(C=C1)Cl)C2=NC(=NN2)SCC(=O)N[C@H](CC3=CNC4=CC=CC=C43)C(=O)OC,KKHUPJKBPNZBFP-GOSISDBHSA-N,"methyl (2R)-2-[[2-[[5-(5-chloro-2-methoxyphenyl)-1H-1,2,4-triazol-3-yl]sulfanyl]acetyl]amino]-3-(1H-indol-3-yl)propanoate",499.108,499.108,0,1,0,1,1,0,0,0,0,0,0,0,"","",0,"",20240206,AbaChemScene|MedChemexpress MCE,Chemical Vendors,""
171037967,Shp2-IN-26,SHP2-IN-26|HY-157888|CS-1007872,465.400,C20H22Cl2N6OS,118.000,612.000,3.700,30,2,7,3,"InChI=1S/C20H22Cl2N6OS/c1-11-17(23)20(10-29-11)5-7-28(8-6-20)14-9-24-16-18(25-14)26-27-19(16)30-13-4-2-3-12(21)15(13)22/h2-4,9,11,17H,5-8,10,23H2,1H3,(H,25,26,27)/t11-,17+/m0/s1",C[C@H]1[C@H](C2(CCN(CC2)C3=CN=C4C(=N3)NN=C4SC5=C(C(=CC=C5)Cl)Cl)CO1)N,PTODQOKWRFFFFB-APPDUMDISA-N,"(3S,4S)-8-[3-(2,3-dichlorophenyl)sulfanyl-1H-pyrazolo[3,4-b]pyrazin-6-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine",464.095,464.095,0,1,0,2,2,0,0,0,0,0,0,0,"","",0,"",20240403,AbaChemScene|MedChemexpress MCE,Chemical Vendors,""
172638573,Shp2-IN-32,SHP2-IN-32|HY-169111,559.100,C29H27ClN6O2S,139.000,985.000,3.800,39,3,8,5,"InChI=1S/C29H27ClN6O2S/c30-26-21(35-28(38)20-15-32-11-8-22(20)37)6-3-7-23(26)39-25-17-33-24(16-34-25)36-12-9-29(10-13-36)14-18-4-1-2-5-19(18)27(29)31/h1-8,11,15-17,27H,9-10,12-14,31H2,(H,32,37)(H,35,38)/t27-/m1/s1",C1CN(CCC12CC3=CC=CC=C3[C@H]2N)C4=CN=C(C=N4)SC5=CC=CC(=C5Cl)NC(=O)C6=CNC=CC6=O,LJZLQBJCDJYZED-HHHXNRCGSA-N,"N-[3-[5-[(1S)-1-aminospiro[1,3-dihydroindene-2,4'-piperidine]-1'-yl]pyrazin-2-yl]sulfanyl-2-chlorophenyl]-4-oxo-1H-pyridine-3-carboxamide",558.16,558.16,0,1,0,1,1,0,0,0,0,0,0,0,"","",0,"",20241231,MedChemexpress MCE|TargetMol,Chemical Vendors,""
172419101,Shp2-IN-30,SHP2-IN-30|HY-162755,449.400,C21H22Cl2N4OS,87.200,786.000,3.700,29,1,5,4,"InChI=1S/C21H22Cl2N4OS/c1-21(13-24)7-9-26(10-8-21)18-11-19(28)27-12-14(5-6-17(27)25-18)29-16-4-2-3-15(22)20(16)23/h2-6,11-12H,7-10,13,24H2,1H3",CC1(CCN(CC1)C2=CC(=O)N3C=C(C=CC3=N2)SC4=C(C(=CC=C4)Cl)Cl)CN,XXBQVYPHUNPLOL-UHFFFAOYSA-N,"2-[4-(aminomethyl)-4-methylpiperidin-1-yl]-7-(2,3-dichlorophenyl)sulfanylpyrido[1,2-a]pyrimidin-4-one",448.089,448.089,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20241114,MedChemexpress MCE,Chemical Vendors,""
